Prevalence and distribution of human papillomavirus genotypes in women with precancerous cervical lesions from urban and rural areas of Cte dIvoire

T. K. Agbessi; A. K. Dotia; R.A. Djatchi; F.S. Zaba; J.S. Lathro; A.M. Cablan; A. Krizo; S. A. Tahou; T. Ouassa; N. Y. Zinzendorf

doi:10.5897/JGMV2024.0083

Journal of
General and Molecular Virology

Abbreviation: J. Gen. Mol. Virol.
Language: English
ISSN: 2141-6648
DOI: 10.5897/JGMV
Start Year: 2009
Published Articles: 38

Full Length Research Paper

Prevalence and distribution of human papillomavirus genotypes in women with precancerous cervical lesions from urban and rural areas of Côte d'Ivoire

T. K. Agbessi

T. K. Agbessi
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

A. K. Dotia

A. K. Dotia
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

R.A. Djatchi

R.A. Djatchi
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

F.S. Zaba

F.S. Zaba
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

J.S. Lathro

J.S. Lathro
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

A.M. Cablan

A.M. Cablan
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

A. Krizo

A. Krizo
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

S. A. Tahou

S. A. Tahou
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

T. Ouassa

T. Ouassa
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

N. Y. Zinzendorf

N. Y. Zinzendorf
Department of Bacteriology and Virology, Faculty of Pharmaceutical and Biological Sciences, University Félix Houphout-Boigny, BP V 34 Abidjan, Côte d’Ivoire.
Search for this author on:
Google Scholar

Article Number - C076DCA73100
Vol.12(1), pp. 1-7 , January 2025
https://doi.org/10.5897/JGMV2024.0083

Received: 19 December 2024
Accepted: 14 March 2025
Published: 31 March 2025

References

Bray F, Ferlay J, Soerjomataram I, Siege RL, Torre LA, Jemal A (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinicians 68(6):394-424. Crossref

Burd EM, Dean CL (2016). Human papillomavirus. Diagnostic Microbiology of the Immunocompromised host. pp. 177-195. Crossref

Clifford GM, Tully S, Franceschi S (2017). Carcinogenicity of human papillomavirus (HPV) types in HIV-positive women: a meta-analysis from HPV infection to cervical cancer. Clinical Infectious Diseases 64(9):1228-1235. Crossref

Didelot-Rousseau MN, Nagot N, Costes-Martineau V, Valles X, Ouedraogo A, Konate I, Segondy M (2006). Human papillomavirus genotype distribution and cervical squamous intraepithelial lesions among high-risk women with and without HIV-1 infection in Burkina Faso. British Journal of Cancer 95(3):355-362. Crossref

Fakhry C, Gillison ML, D'Souza G (2014). Tobacco use and oral HPV-16 infection. Jama 312(14):1465-1467. Crossref

Fane S, Bocoum A, Sylla C, Traoré SO, Traoré S, Traoré Y, Mounkoro N (2022). Le Cancer du Col chez les Femmes Séropositives au VIH au CHU Gabriel Toure de Bamako: Prévalence et Évaluation du Niveau des Connaissances: Cervical cancer among women living with HIV at the Gabriel Toure University Hospital of Bamako: prevalence and assessment of knowledge. Health Sciences and Disease 23(5):22.

Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F (2021). Cancer statistics for the year 2020: An overview. International Journal of Cancer 149(4):778-789. Crossref

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. International Journal of Cancer 127(12):2893-2917. Crossref

Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Franceschi S (2012). Global burden of human papillomavirus and related diseases. Vaccine 30:F12-F23. Crossref

Global cancer observatory (Globocan) (2022). International agency of research cancer cote divoire-fact-sheet. P 384. View

Hantz S (2021). Human papillomavirus: screening and prevention. RFL 530: 60-70. Crossref

Hatzipanagiotou M, Dana H, Françoise M, Michael P,Jürgen W (2018). Human papillomaviruses in Western Africa: prevalences and risk factors in Burkina Faso. Archives of Gynecology and Obstetrics 298:789-796. Crossref

Houlihan CF, Larke NL, Watson-Jones D, Smith-McCune KK, Shiboski S, Gravitt PE, Smith JS, Kuhn L, Wang C, Hayes R (2012). Human papillomavirus infection and increased risk of HIV acquisition. A systematic review and meta-analysis. Aids 26(17):2211-22122. Crossref

International Agency for Research on Cancer (2012). Review of human carcinogens (Volume 100). World health organization.

Jaquet A, Horo A, Charbonneau V, Ekouevi DK, Roncin L, Toure B, Coffie P, Minga A, Sasco AJ, Garrigue I, Fleury H (2012). Cervical human papillomavirus and HIV infection in women of child-bearing age in Abidjan, Cote d'Ivoire, 2010. British Journal of Cancer 107(3):556-563. Crossref

Ogembo RK, Gona PN, Seymour AJ, Park HSM, Bain PA, Maranda L, Ogembo JG (2015). Prevalence of human papillomavirus genotypes among African women with normal cervical cytology and neoplasia: a systematic review and meta-analysis. PloS one 10(4):e0122488. Crossref

Peng RR, Li HM, Chang H, Li JH, Wang AL, Chen XS (2011). Prevalence and genotype distribution of cervical human papillomavirus infection among female sex workers in Asia: a systematic literature review and meta-analysis. Sexual Health 9(2):113-119. Crossref

Segondy M (2008). Classification des papillomavirus (HPV). Revue francophone des laboratoires 405:23-25. Crossref

Stelzle D, Tanaka LF, Lee KK, Khalil AI, Baussano I, Shah AS, Dalal S (2021). Estimates of the global burden of cervical cancer associated with HIV. The Lancet Global Health 9(2):e161-e169. Crossref

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A,Bray F (2021). Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. A Cancer Journal for Clinician 71(3):209-249. Crossref

Taylor S, Bunge E, Bakker M, Castellsagué X (2016). The incidence, clearance and persistence of non-cervical human papillomavirus infections: a systematic review of the literature. BMC Infectious Diseases 16:1-21. Crossref

Tebeu PM, Sandjong I, Nkele N, Fokoua S, Achu P, Kouam L, DOH AS (2005). Precancerous lesions of the cervix in rural areas: A cross-sectional study. Medicine of Black Africa 52:23.

Valentin Dufit, Antoine Adenis, Maylis Douine, Fatiha Najioullah, Odile Kilie, Vincent Molinie, Dominique Catherine, Nadia Thomas, Jean-Luc Deshayes, Brousse P (2016). Epidemiology of human papillomavirus infection in women aged 20-65 years residing in isolated communes of French Guyana. Bulletin d'épidémiologie Hebdomadaire 34:588-597.

Veldhuijzen NJ, Braunstein SL, Vyankandondera J, Ingabire C, Ntirushwa J, Kestelyn E,van de Wijgert JH (2011). The epidemiology of human papillomavirus infection in HIV-positive and HIV-negative high-risk women in Kigali, Rwanda. BMC Infectious Diseases 11:1-14. Crossref

World Health Organization (WHO) (2024). Cervical cancer.

World Health Organization (WHO) (2021). Guideline for screening and treatment of cervical pre-cancer lesions for cervical cancer prevention, second edition. Geneva: P 115. Licence: CC BY-NC-SA 3.0 IGO.

World Health Organization (WHO) (2017) Weekly Epidemiological Record 92(19):241-268. View

Zinzendorf NY, Cablan MA, Zaba FS, Apeté-Tahou S, Brou KP, Ouassa T, Dotia A, Lathro SJ, Agbessi-Kouassi BT (2022). Prevalence and distribution of human papillomavirus genotypes in HIV-positive and HIV- negative young women aged 20-37 years with cervical cancer in Abidjan, Côte d'Ivoire. International Journal of Virology and AIDS 9:1-7.